A breakthrough test developed by Indiana University School of Medicine researchers to measure pain in patients could help stem the tide of the opioid crisis in Indiana, and throughout the rest of the nation.
A study led by psychiatry professor Alexander Niculescu, MD, PhD and published this week in the high impact Nature journal Molecular Psychiatry tracked hundreds of participants at the Richard L. Roudebush VA Medical Center in Indianapolis to identify biomarkers in the blood that can help objectively determine how severe a patient’s pain is. The blood test, the first of its kind, would allow physicians far more accuracy in treating pain—as well as a better long-term look at the patient’s medical future.
“We have developed a prototype for a blood test that can objectively tell doctors if the patient is in pain, and how severe that pain is. It’s very important to have an objective measure of pain, as pain is a subjective sensation. Until now we have had to rely on patients self-reporting or the clinical impression the doctor has,” said Niculescu, who worked with other Department of Psychiatry researchers on the study. “When we started this work it was a farfetched idea. But the idea was to find a way to treat and prescribe things more appropriately to people who are in pain.”
During the study, researchers looked at biomarkers found in the blood—in this case molecules that reflect disease severity. Much like as glucose serves as a biomarker to diabetes, these biomarkers allow doctors to assess the severity of the pain the patient is experiencing, and provide treatment in an objective, quantifiable manner. With an opioid epidemic raging throughout the state and beyond, Niculescu said never has there been a more important time to administer drugs to patients responsibly.
“The opioid epidemic occurred because addictive medications were overprescribed due to the fact that there was no objective measure whether someone was in pain, or how severe their pain was,” Niculescu said. “Before, doctors weren’t being taught good alternatives. The thought was that this person says they are in pain, let’s prescribe it. Now people are seeing that this created a huge problem. We need alternatives to opioids, and we need to treat people in a precise fashion. This test we’ve developed allows for that.”
In addition to providing an objective measure of pain, Niculescu’s blood test helps physicians match the biomarkers in the patient’s blood with potential treatment options. Like a scene out of CSI, researchers utilize a prescription database—similar to fingerprint databases employed by the FBI—to match the pain biomarkers with profiles of drugs and natural compounds cataloged in the database.
“The biomarker is like a fingerprint, and we match it against this database and see which compound would normalize the signature,” said Niculescu, adding that often the best treatment identified is a non-opioid drug or compound. “We found some compounds that have been used for decades to treat other things pair the best with the biomarkers. We have been able to match biomarkers with existing medications, or natural compounds, which would reduce or eliminate the need to use the opioids.”
In keeping with the IU Grand Challenge Precision Health Initiative launched in June 2016, this study opens the door to precision medicine for pain. By treating and prescribing medicine more appropriately to the individual person, this prototype may help alleviate the dilemmas that have contributed to the current opioid epidemic.
“In any field, the goal is to match the patient to the right drug, which hopefully does a lot of good and very little harm,” Niculescu said. “But through precision health, by having lots of options geared toward the needs of specific patients, you prevent larger problems, like the opioid epidemic, from occurring.”
Additionally, study experts discovered biomarkers that not only match with non-addictive drugs that can treat pain, but can also help predict when someone might experience pain in the future—helping to determine if a patient is exhibiting chronic, long-term pain which might result in future emergency room visits.
“Through precision medicine you’re giving the patient treatment that is tailored directly to them and their needs,” Niculescu said. “We wanted first to find some markers for pain that are universal, and we were able to. We know, however, based on our data that there are some markers that work better for men, some that work better for women. It could be that there are some markers that work better for headaches, some markers that work better for fibromyalgia and so on. That is where we hope to go with future larger studies.”
The study was supported by an NIH Director’s New Innovator Award and a VA Merit Award. Moving forward, Niculescu’s group looks to secure more funding through grants or outside philanthropy to continue and accelerate these studies—with the hopes of personalizing the approach even more and moving toward a clinical application. A self-described longshot at the start, Niculescu said that the work his group has done could have a major impact on how doctors around the world treat pain in the future.
“It’s been a goal of many researchers and a dream to find biomarkers for pain,” Niculescu said. “We have come out of left field with an approach that had worked well in psychiatry for suicide and depression in previous studies. We applied it to pain, and we were successful. I give a lot of credit for that to my team at IU School of Medicine and the Indianapolis VA, as well as the excellent environment and support we have.”
Learn more: IU School of Medicine makes breakthrough toward developing blood test for pain
The Latest on: Pain
[google_news title=”” keyword=”pain” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pain
- Former NFL player recovers without opioids, hoping to be example of pain treatments without pillson May 10, 2024 at 6:42 pm
KNOXVILLE, Tenn. — Doctors are starting to rethink pain treatments, hoping to find new ways to help people without prescribing opioids. A former NFL player is hoping to lead as an example of how ...
- Brad Marchand visibly in pain on Bruins’ bench after brutal collision, leaves gameon May 10, 2024 at 6:17 pm
It is that time of the year where play goes up a notch and players get banged up, and it is no different for Boston Bruins’ captain Brad Marchand. In the first period of Game 3 of the second round ...
- Jelly Roll honors Toby Keith with T-Pain as part of guest-filled Stagecoach seton May 10, 2024 at 12:00 pm
Jelly Roll, one of country music's fastest-rising stars, squeezed multiple guests into his 50-minute set at the Stagecoach country music festival Friday night highlighted by a team-up with rapper ...
- The West eyes Russian LNG as pain point for sanctionson May 10, 2024 at 11:18 am
The European Union is negotiating a ban on Russian liquefied natural gas exports in its latest sanctions package, bolstering U.S. actions to restrict Russia's fossil fuel revenue, slow construction of ...
- Prelude Dark Pain may look like isometric Darkest Dungeon, but its influences run deeperon May 10, 2024 at 8:00 am
Prelude Dark Pain blends Darkest Dungeon, Bloodborne, and Final Fantasy Tactics to great effect, though we've yet to experience its open world.
- Health and Wellness: Why your nagging shoulder blade pain isn't going awayon May 10, 2024 at 7:25 am
The prevalence of shoulder pain tends to increase and become more severe as we age - especially for folks in their 50’s and beyond. When people complain of shoulder pain - it can manifest in a lot of ...
- ‘Doctors Dismissed My Pain As An Ingrown Hair. It Turned Out to Be A Severe Neurological Condition’on May 10, 2024 at 5:00 am
Common causes of pudendal neuralgia are vaginal birth and surgeries such as dilatation and curettage (D&C) procedures or C-sections—but the condition can also occur in cyclists or horseback riders ...
- ‘I Had Severe Pelvic Pain After Giving Birth—Here’s What Doctors Missed’on May 10, 2024 at 5:00 am
But about a year later, in 2018, pain started, and I brought it to my ob-gyn’s attention. It wasn’t just any pain: It began in my right inner leg where the episiotomy scar was. From there, it traveled ...
- This strange brain reaction to pain is called ‘muscle guarding’on May 9, 2024 at 4:20 pm
Muscle guarding, which emanates from the brain, is a physical response to pain. For some, though, protracted muscle guarding can prolong pain and inhibit recovery. Clark mentioned helping a female ...
- ‘The pain is just so hard’: Parents hope story of daughter’s death after consuming Panera beverage will save otherson May 9, 2024 at 11:08 am
Panera Bread has decided to stop selling its “Charged Sips” drinks following reports of the deaths of at least two individuals who consumed the caffeinated beverages.
via Bing News